GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 35 filers reported holding GLAXOSMITHKLINE PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $101,543,000 | +0.0% | 2,332,702 | +0.1% | 0.04% | +16.1% |
Q1 2022 | $101,536,000 | -1.4% | 2,330,957 | -0.2% | 0.03% | 0.0% |
Q4 2021 | $102,955,000 | +15.6% | 2,334,586 | +0.2% | 0.03% | +6.9% |
Q3 2021 | $89,071,000 | -6.2% | 2,331,081 | -2.2% | 0.03% | -3.3% |
Q2 2021 | $94,931,000 | +8.1% | 2,384,015 | -3.1% | 0.03% | +3.4% |
Q1 2021 | $87,814,000 | -3.1% | 2,460,461 | -0.1% | 0.03% | -12.1% |
Q4 2020 | $90,658,000 | -13.2% | 2,463,541 | -11.3% | 0.03% | -25.0% |
Q3 2020 | $104,494,000 | -19.4% | 2,776,150 | -12.7% | 0.04% | -22.8% |
Q2 2020 | $129,674,000 | +7.6% | 3,179,062 | -0.1% | 0.06% | -9.5% |
Q1 2020 | $120,564,000 | -5.2% | 3,181,937 | +17.6% | 0.06% | +37.0% |
Q4 2019 | $127,176,000 | +18.9% | 2,706,447 | +8.0% | 0.05% | +9.5% |
Q3 2019 | $106,993,000 | +14.3% | 2,506,860 | +7.2% | 0.04% | +16.7% |
Q2 2019 | $93,599,000 | +8.4% | 2,338,799 | +13.2% | 0.04% | +5.9% |
Q1 2019 | $86,318,000 | +27.6% | 2,065,528 | +16.7% | 0.03% | +9.7% |
Q4 2018 | $67,626,000 | +0.1% | 1,769,859 | +5.2% | 0.03% | +19.2% |
Q3 2018 | $67,554,000 | +2.1% | 1,681,711 | +2.5% | 0.03% | 0.0% |
Q2 2018 | $66,136,000 | +1.2% | 1,640,680 | -1.9% | 0.03% | -3.7% |
Q1 2018 | $65,330,000 | +14.9% | 1,672,125 | +4.3% | 0.03% | +12.5% |
Q4 2017 | $56,878,000 | -12.4% | 1,603,564 | +0.3% | 0.02% | -14.3% |
Q3 2017 | $64,894,000 | -5.5% | 1,598,363 | +0.4% | 0.03% | -12.5% |
Q2 2017 | $68,673,000 | +11.5% | 1,592,604 | +9.0% | 0.03% | +10.3% |
Q1 2017 | $61,609,000 | +10.2% | 1,461,320 | +0.7% | 0.03% | +3.6% |
Q4 2016 | $55,891,000 | -8.9% | 1,451,342 | +2.1% | 0.03% | -15.2% |
Q3 2016 | $61,327,000 | +3.1% | 1,421,902 | +3.6% | 0.03% | -2.9% |
Q2 2016 | $59,491,000 | +10.4% | 1,372,656 | +3.3% | 0.03% | +6.2% |
Q1 2016 | $53,891,000 | +6.4% | 1,329,012 | +5.9% | 0.03% | 0.0% |
Q4 2015 | $50,640,000 | +10.2% | 1,255,017 | +5.0% | 0.03% | +6.7% |
Q3 2015 | $45,973,000 | -7.6% | 1,195,662 | +0.1% | 0.03% | 0.0% |
Q2 2015 | $49,731,000 | -9.2% | 1,194,013 | +0.6% | 0.03% | -14.3% |
Q1 2015 | $54,762,000 | +16.0% | 1,186,608 | +7.4% | 0.04% | +12.9% |
Q4 2014 | $47,227,000 | +5.1% | 1,104,982 | +13.0% | 0.03% | -3.1% |
Q3 2014 | $44,953,000 | -8.7% | 977,885 | +6.2% | 0.03% | -5.9% |
Q2 2014 | $49,234,000 | +4.3% | 920,608 | +4.2% | 0.03% | -2.9% |
Q1 2014 | $47,216,000 | +34.9% | 883,694 | +34.8% | 0.04% | +29.6% |
Q4 2013 | $34,991,000 | +20.7% | 655,381 | +13.4% | 0.03% | +8.0% |
Q3 2013 | $28,990,000 | +27.7% | 577,842 | +27.2% | 0.02% | +19.0% |
Q2 2013 | $22,702,000 | – | 454,310 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |